Skip to main content
. 2022 Dec 12:1–8. Online ahead of print. doi: 10.1007/s10238-022-00964-4

Table 4.

Variables associated with progression in remdesivir recipients, n = 27

Progressed (%) Did not progress p
Number of remdesivir doses, n = 26
3 3 (15.8) 16 (84.2) 0.057a
5 4 (57.1) 3 (42.9)
Time from onset of symptoms to remdesivir administration
0–7 days 4 (16.7) 20 (83.3) 0.012a
 > 7 days 3 (100) 0 (0)
Ambulatory remdesivir
Yes 0 9 (100) 0.036a
No 7 (31.9) 11 (61.1)

aFisher exact test